Hanfelt J J, Slack R S, Gehan E A
Department of Biostatistics, Rollins School of Public Health of Emory University, Atlanta, Georgia 30322, USA.
Control Clin Trials. 1999 Dec;20(6):555-66. doi: 10.1016/s0197-2456(99)00028-8.
We present a modification to Simon's optimal design for phase II trials in which the objective is to minimize the median sample size rather than the expected sample size when the true response rate is poor (p = p0). We argue that the modified design may be preferred in smaller institutions when the focus is on a single or small number of phase II trials rather than a large program of phase II trials.
我们提出了一种对西蒙用于II期试验的最优设计的修改方法,该设计的目标是在真实缓解率较低(p = p0)时使中位样本量最小化,而非预期样本量最小化。我们认为,当重点在于单个或少量II期试验而非大型II期试验项目时,较小机构可能更倾向于采用这种修改后的设计。